JP2022180437A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022180437A5 JP2022180437A5 JP2022143467A JP2022143467A JP2022180437A5 JP 2022180437 A5 JP2022180437 A5 JP 2022180437A5 JP 2022143467 A JP2022143467 A JP 2022143467A JP 2022143467 A JP2022143467 A JP 2022143467A JP 2022180437 A5 JP2022180437 A5 JP 2022180437A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- hom
- monocytes
- inhibitor
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024153550A JP2024170560A (ja) | 2016-02-04 | 2024-09-06 | 炎症性障害の治療及び診断 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662291271P | 2016-02-04 | 2016-02-04 | |
| US62/291,271 | 2016-02-04 | ||
| JP2018560436A JP2019512018A (ja) | 2016-02-04 | 2017-01-31 | 炎症性障害の治療及び診断 |
| PCT/US2017/015775 WO2017136322A1 (en) | 2016-02-04 | 2017-01-31 | Treatment and diagnosis of inflammatory disorders |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018560436A Division JP2019512018A (ja) | 2016-02-04 | 2017-01-31 | 炎症性障害の治療及び診断 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024153550A Division JP2024170560A (ja) | 2016-02-04 | 2024-09-06 | 炎症性障害の治療及び診断 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022180437A JP2022180437A (ja) | 2022-12-06 |
| JP2022180437A5 true JP2022180437A5 (cg-RX-API-DMAC7.html) | 2023-03-07 |
| JP7635939B2 JP7635939B2 (ja) | 2025-02-26 |
Family
ID=59499992
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018560436A Pending JP2019512018A (ja) | 2016-02-04 | 2017-01-31 | 炎症性障害の治療及び診断 |
| JP2022143467A Active JP7635939B2 (ja) | 2016-02-04 | 2022-09-09 | 炎症性障害の治療及び診断 |
| JP2024153550A Pending JP2024170560A (ja) | 2016-02-04 | 2024-09-06 | 炎症性障害の治療及び診断 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018560436A Pending JP2019512018A (ja) | 2016-02-04 | 2017-01-31 | 炎症性障害の治療及び診断 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024153550A Pending JP2024170560A (ja) | 2016-02-04 | 2024-09-06 | 炎症性障害の治療及び診断 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US11268095B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3411479A4 (cg-RX-API-DMAC7.html) |
| JP (3) | JP2019512018A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20180109985A (cg-RX-API-DMAC7.html) |
| CN (1) | CN108779461A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2017213744B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3013898A1 (cg-RX-API-DMAC7.html) |
| CL (3) | CL2018002097A1 (cg-RX-API-DMAC7.html) |
| IL (2) | IL260987B2 (cg-RX-API-DMAC7.html) |
| MX (2) | MX2018009542A (cg-RX-API-DMAC7.html) |
| MY (2) | MY194135A (cg-RX-API-DMAC7.html) |
| SG (2) | SG10201913129QA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017136322A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL260987B2 (en) | 2016-02-04 | 2024-09-01 | Zhenglun Zhu | Treatment and diagnosis of inflammatory disorders |
| KR20220011123A (ko) | 2019-04-11 | 2022-01-27 | 엔클리어 테라피스, 인크. | 뇌척수액 개선 방법 및 이를 위한 디바이스 및 시스템 |
| CN111528842B (zh) * | 2020-05-26 | 2023-01-03 | 复嶂环洲生物科技(上海)有限公司 | 基于生理和行为指标的帕金森病症状定量化评估方法 |
| JP2023543868A (ja) | 2020-09-29 | 2023-10-18 | エンクリアー セラピーズ， インク． | くも膜下液管理方法およびシステム |
| AU2022297513A1 (en) * | 2021-06-23 | 2024-01-18 | Enclear Therapies, Inc. | Method of regulating gene expression |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2709309B1 (fr) | 1993-08-25 | 1995-11-10 | Centre Nat Rech Scient | Compositions cellulaires, préparation et utilisations thérapeutiques. |
| US5583153A (en) | 1994-10-06 | 1996-12-10 | Regents Of The University Of California | Use of taxol in the treatment of rheumatoid arthritis |
| US20030035790A1 (en) | 1999-01-15 | 2003-02-20 | Shu-Hsia Chen | Combination therapy for the prevention or treatment of cancer, inflammatory disorders or infectious diseases in a subject |
| EP1222933A1 (en) | 2001-01-15 | 2002-07-17 | Academisch Ziekenhuis Leiden h.o.d.n., Leids Universitair Medisch Centrum | Generation and/or reduction of new lung tissue in an affected lung, by modulation of the Wnt-pathway |
| US20040142325A1 (en) | 2001-09-14 | 2004-07-22 | Liat Mintz | Methods and systems for annotating biomolecular sequences |
| KR20050115231A (ko) | 2003-02-10 | 2005-12-07 | 내셔날 인스티튜트 오브 어드밴스드 인더스트리얼 사이언스 앤드 테크놀로지 | 포유동물 세포의 조절 |
| EP1712563A4 (en) | 2004-01-27 | 2008-05-28 | Medical & Biol Lab Co Ltd | METHOD FOR ISOLATING MONOCYTES |
| WO2006086345A2 (en) | 2005-02-07 | 2006-08-17 | The Trustees Of Columbia University In The City Of New York | Methods to treat or prevent hormone-resistant prostate cancer using sirna specific for protocadherin-pc, or other inhibitors of protocadherin-pc expression or activity |
| WO2007051077A2 (en) | 2005-10-28 | 2007-05-03 | The Regents Of The University Of California | Methods and compounds for lymphoma cell detection and isolation |
| WO2007078599A2 (en) | 2005-12-16 | 2007-07-12 | The Board Of Trustees Of The Leland Stanford Junior University | Functional arrays for high throughput characterization of gene expression regulatory elements |
| US20070161031A1 (en) | 2005-12-16 | 2007-07-12 | The Board Of Trustees Of The Leland Stanford Junior University | Functional arrays for high throughput characterization of gene expression regulatory elements |
| EP2612675A1 (en) * | 2006-02-22 | 2013-07-10 | Zhenglun Zhu | Treatment of development-related disorders |
| HUE042736T2 (hu) | 2009-07-15 | 2019-07-29 | Zhenglun Zhu | Gyulladásos vagy autoimmun rendellenességek kezelésének irányítása HOM-1 kifejezés alkalmazásával |
| CN103415615B (zh) * | 2010-11-24 | 2015-11-25 | 高红 | 扩增造血干细胞 |
| WO2012170979A1 (en) * | 2011-06-10 | 2012-12-13 | Zhenglun Zhu | Human homeobox gene ventx and macrophage terminal differentiation and activation, compositions and methods thereof |
| EP2961405A4 (en) | 2012-12-14 | 2017-03-29 | The Brigham and Women's Hospital, Inc. | Methods and assays relating to macrophage differentiation |
| JP6559117B2 (ja) * | 2013-04-10 | 2019-08-14 | ツェンルン チュー | ヒト樹状細胞の分化および成熟を調節するホメオボックス転写因子ＶｅｎｔＸ |
| US9428748B2 (en) * | 2013-06-17 | 2016-08-30 | Hong Gao | Method of expanding hematopoietic stem cells |
| SG10201913151TA (en) | 2015-09-09 | 2020-03-30 | Seattle Childrens Hospital Dba Seattle Childrens Res Inst | Genetic engineering of macrophages for immunotherapy |
| EP3973968A3 (en) | 2015-11-11 | 2022-06-08 | Zhenglun Zhu | Method of modifying macrophage differentiation and immunity |
| IL260987B2 (en) | 2016-02-04 | 2024-09-01 | Zhenglun Zhu | Treatment and diagnosis of inflammatory disorders |
| WO2018183447A1 (en) | 2017-03-28 | 2018-10-04 | Zhenglun Zhu | Methods of treating neoplastic diseases |
-
2017
- 2017-01-31 IL IL260987A patent/IL260987B2/en unknown
- 2017-01-31 US US16/075,479 patent/US11268095B2/en active Active
- 2017-01-31 WO PCT/US2017/015775 patent/WO2017136322A1/en not_active Ceased
- 2017-01-31 MX MX2018009542A patent/MX2018009542A/es unknown
- 2017-01-31 CN CN201780016917.2A patent/CN108779461A/zh active Pending
- 2017-01-31 KR KR1020187025087A patent/KR20180109985A/ko not_active Ceased
- 2017-01-31 JP JP2018560436A patent/JP2019512018A/ja active Pending
- 2017-01-31 MY MYPI2018702738A patent/MY194135A/en unknown
- 2017-01-31 IL IL311968A patent/IL311968B1/en unknown
- 2017-01-31 SG SG10201913129QA patent/SG10201913129QA/en unknown
- 2017-01-31 CA CA3013898A patent/CA3013898A1/en active Pending
- 2017-01-31 AU AU2017213744A patent/AU2017213744B2/en active Active
- 2017-01-31 EP EP17748003.5A patent/EP3411479A4/en active Pending
- 2017-01-31 MY MYPI2021007385A patent/MY203831A/en unknown
- 2017-01-31 SG SG11201806636SA patent/SG11201806636SA/en unknown
-
2018
- 2018-08-03 MX MX2022010890A patent/MX2022010890A/es unknown
- 2018-08-03 CL CL2018002097A patent/CL2018002097A1/es unknown
-
2021
- 2021-12-29 CL CL2021003543A patent/CL2021003543A1/es unknown
-
2022
- 2022-02-18 US US17/675,800 patent/US12146138B2/en active Active
- 2022-09-09 JP JP2022143467A patent/JP7635939B2/ja active Active
-
2023
- 2023-09-22 AU AU2023233180A patent/AU2023233180B2/en active Active
- 2023-10-06 CL CL2023003003A patent/CL2023003003A1/es unknown
-
2024
- 2024-09-06 JP JP2024153550A patent/JP2024170560A/ja active Pending
- 2024-10-17 US US18/918,938 patent/US20250188474A1/en active Pending